US 8,273,751 B2Granted

Organic compounds

AssigneeTakeda Pharmaceutical Company Limited

InventorPeng Li

Life of this patent

Estimating the term…

Abstract

1- or 2-substituted (6aR,9aS)-3-(phenylamino)-5-6a,7,8,9,9a-hexahydro-5-methyl-cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(1H or, 2H)-one compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Claims3

Dependent claims

The compound (6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)-cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one according to the following formula:

in free or salt form.

Dependencies are inferred from the claim text.

Facts

Application: 12/746,236Filed 6 Dec 2008 · us provisional application
Priority: 6 Dec 2007
Published: US 2010/0273754 A128 Oct 2010
Granted: 25 Sep 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification39 codes

C07D 487/14
In which the condensed system contains three hetero rings: ortho-condensed systems
A61K 31/519
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with heterocyclic rings
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 5/14
Drugs for disorders of the endocrine system: of the thyroid hormones, e.g. T3, T4

Family

Application61/012,040Us provisional application · filed 6 Dec 2007
US 2010/0273754 A1Pre-grant publication · published 28 Oct 2010
US 8,273,751 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results